Yat Sun Or insider trades: Enanta Pharmaceuticals (ENTA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yat reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | ENTA | ↓ Sell | 2,390 | $14.23 | $34K | Direct | Dec 5, 2025 (0d) |
| Dec 6, 2024 | ENTA | ↓ Sell | 2,591 | $8.06 | $21K | Direct | Dec 10, 2024 (4d) |
| Dec 5, 2023 | ENTA | ↓ Sell | 2,412 | $9.63 | $23K | Direct | Dec 6, 2023 (1d) |
| Mar 15, 2023 | ENTA | ↓ Sell | 13,925 | $44.45 | $619K | Direct | Mar 17, 2023 (2d) |
| Mar 1, 2019 | ENTA | ↓ Sell | 10,000 | $103.53 | $1.0M | Direct | Mar 4, 2019 (3d) |
| Feb 12, 2019 | ENTA | ↓ Sell | 33,981 | $89.52 | $3.0M | Direct | Feb 13, 2019 (1d) |
| Jan 4, 2017 | ENTA | ↓ Sell | 13,921 | $35.09 | $489K | Direct | Jan 5, 2017 (1d) |
| Nov 29, 2016 | ENTA | ↓ Sell | 13,921 | $31.44 | $438K | Direct | Nov 30, 2016 (1d) |
| Aug 10, 2015 | ENTA | ↓ Sell | 3,750 | $42.90 | $161K | Direct | Aug 11, 2015 (1d) |
| Jul 13, 2015 | ENTA | ↓ Sell | 3,750 | $46.29 | $174K | Direct | Jul 14, 2015 (1d) |
| Jun 11, 2015 | ENTA | ↓ Sell | 3,750 | $42.47 | $159K | Direct | Jun 15, 2015 (4d) |
| Jun 5, 2015 | ENTA | ↓ Sell | 10,750 | $42.02 | $452K | Direct | Jun 8, 2015 (3d) |
| May 11, 2015 | ENTA | ↓ Sell | 8,000 | $36.13 | $289K | Direct | May 12, 2015 (1d) |
| Aug 13, 2014 | ENTA | ↓ Sell | 5,000 | $39.49 | $197K | Direct | Aug 15, 2014 (2d) |
| Jul 1, 2014 | ENTA | ↓ Sell | 5,000 | $42.24 | $211K | Direct | Jul 3, 2014 (2d) |
| Jun 2, 2014 | ENTA | ↓ Sell | 5,000 | $37.56 | $188K | Direct | Jun 4, 2014 (2d) |
| May 1, 2014 | ENTA | ↓ Sell | 5,000 | $36.98 | $185K | Direct | May 2, 2014 (1d) |
| Apr 1, 2014 | ENTA | ↓ Sell | 10,000 | $39.16 | $392K | Direct | Apr 2, 2014 (1d) |
| Mar 24, 2014 | ENTA | ↓ Sell | 10,000 | $39.34 | $393K | Direct | Mar 25, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ENTA insiders
Open-market trades in the last 12 months
About Yat Sun Or's insider trades
Yat Sun Or is Chief Scientific Officer at Enanta Pharmaceuticals (ENTA). Since Mar 24, 2014, Yat has reported no open-market purchases and 19 sales worth $8.5M on SEC Form 4. In the last 12 months: 1 sale ($34K).
Their filings also include grants and awards (27 filings), shares withheld for taxes (15 filings), option exercises (10 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.